Akums Gets CDSCO Nod for Colchicine
The Story:
Sanofi Healthcare India has acquired a 15.19% stake in Sanofi India for ₹1,068.2 crore, with the shares transferred internally from fellow promoter entity Hoechst GmbH.
The Take:
The transaction is an internal promoter-group reshuffle that leaves overall Sanofi control and combined promoter ownership unchanged.
Anupam Rasayan Completes Bliss GVS Acquisition
The Story:
Anupam Rasayan has completed the acquisition of a 48.2% controlling stake in Bliss GVS Pharma, adding 150+ branded formulations and six manufacturing facilities to its portfolio.
The Take:
The deal expands Anupam Rasayan into finished-dose formulations and creates a combined pharma and specialty chemicals platform with projected revenue of over ₹4,000 crore.
Sun Pharma, LIB Therapeutics Sign Lerodalcibep Deal
The Story:
Sun Pharma has signed an exclusive licensing agreement with LIB Therapeutics for lerodalcibep, gaining rights to manufacture and commercialize the once-monthly PCSK9 inhibitor globally, excluding the US and China.
The Take:
The deal strengthens Sun Pharma’s innovative medicines portfolio and expands its presence in the growing PCSK9 cholesterol-lowering market.
Sanofi Healthcare Acquires 15.2% Stake in Sanofi India
The Story:
Sanofi Healthcare India has acquired a 15.19% stake in Sanofi India for ₹1,068.2 crore, with the shares transferred internally from fellow promoter entity Hoechst GmbH.
The Take:
The transaction is an internal promoter-group reshuffle that leaves overall Sanofi control and combined promoter ownership unchanged.
